you are viewing a single comment's thread.
Will need now to market Dacogen harder to replace they're main drug fall off in sales. Supg just can't catch a break.
Correct me if I'm wrong, but if MGI Pharma is marketing Dacogen harder, then would sales not have a greater chance of exceeding expectations?Aloxi screw up could shift the focus of MGI sales persons to making sure Dacogen succeeds.This was a break.
Not really because anything that is perceived as being a benefit to a biotech is really not.I can't believe SUPG is not down ah, it will be tommorrow.